Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinib.
- Published in:
- Lipids in Health & Disease, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12944-021-01596-5
- By:
- Publication type:
- Article
Works by Tang, Mengqiu
Results: 6
1
2
Inflammation‐based prognostic scoring system for predicting the prognosis of advanced small cell lung cancer patients receiving anlotinib monotherapy.
- Published in:
- Journal of Clinical Laboratory Analysis, 2022, v. 36, n. 12, p. 1, doi. 10.1002/jcla.24772
- By:
- Publication type:
- Article
3
Prognostic value of prognostic nutritional index and its variations in advanced non‐small‐cell lung cancer patients treated with anlotinib monotherapy.
- Published in:
- Journal of Clinical Laboratory Analysis, 2022, v. 36, n. 4, p. 1, doi. 10.1002/jcla.24300
- By:
- Publication type:
- Article
4
Enhancing Patient Outcomes: A Novel Nomogram Prediction Model Based on Systemic Immune‐Inflammation Index for Esophageal Stricture After Endoscopic Submucosal Dissection.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 18, p. 1, doi. 10.1002/cam4.70264
- By:
- Publication type:
- Article
5
Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 1075, doi. 10.2147/CMAR.S294344
- By:
- Publication type:
- Article
6
Pretreatment lymphocyte-tomonocyte ratio as a prognostic factor and influence on doseeffect in fractionated stereotactic radiotherapy for oligometastatic brain metastases in non-small cell lung cancer patients.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1216852
- By:
- Publication type:
- Article